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Photoactive chelates for radiolabelling proteins
Larissa S. Eichenberger,a Malay Patraa,∆ and Jason P. Holland*a 
Photochemical reactions are an attractive foundation for the 
synthesis of radiolabelled antibodies, immunoglobulin fragments 
and other proteins/peptides. The synthesis, 68Ga-radiochemistry 
and photochemical reactivity of three macrocyclic chelates 
functionalised with an arylazide group is described. Experiments 
with trastuzumab confirm that photoradiochemistry facilitates 
fast, one-pot synthesis of radiolabelled proteins.
Standard methods for radiolabelling biologically active proteins 
or peptides with radionuclides like 64Cu, 68Ga, 89Zr, 90Y, 111In, 
177Lu and 225Ac etc, rely almost exclusively on thermochemical 
processes.[1] For instance, the synthesis of radiolabelled 
monoclonal antibodies (mAbs) for use in immuno-positron 
emission tomography (immuno-PET) or radioimmunotherapy 
(RIT) usually requires pre-functionalisation of the protein with a 
metal ion binding chelate, followed by radiolabelling in the final 
step. Many methods exist for coupling the chelate to the 
protein.[2] These include the use of ‘activated’ reagents based 
on esters, maleimido groups or para-substituted benzyl-
isothiocyanates that facilitate coupling to reactive lysine or 
cysteine residues via amide or thioester bond formation. 
Bioorthogonal approaches that utilise ‘click’ chemistry, or site-
specific enzymatic ligation of the glycoprotein have also shown 
promise.[3,4] However, the conjugation kinetics and overall 
efficiency of each of these methods is ultimately limited by 
thermochemistry.[5] Heating reactions can often increase the 
rates of the conjugation or radiolabelling steps but for most 
proteins, thermal stability is a key concern. 
Photochemistry harbours a diverse array of reactions that 
are useful in the synthesis of organic compounds.[6] However, 
only a handful of examples exist where photochemistry has 
been used in the synthesis of radiolabelled compounds.[7–17] We 
recently demonstrated that a one-pot, photoradiochemical 
process involving 68Ga-radiolabelling of a macrocyclic chelate 
and photochemical conjugation with proteins in situ facilitates 
the direct synthesis, purification and formulation of 68Ga-
labelled mAbs in <20 min.[18] In efforts to expand the 
radiochemical scope of this photoradiochemical approach, here 
we report the synthesis, characterisation and 68Ga-
radiochemistry of three new photoreactive chelates derived 
from the aza-macrocycles NOTA, DOTA and DOTAGA. These 
chelates offer different numbers of donor groups, cavity sizes, 
and overall charges that can be tuned for coordination of 
radioactive metal ions (with formal oxidation states of +2, +3, 
+4 or +5) from across p-, d- and f-blocks.[19]
The photoactive chelates, NOTA-PEG3-ArN3 (1), DOTA-PEG4-
ArN3 (3) and DOTA-PEG4-ArN3 (4) were synthesised via standard 
chemical transformations starting from 4-azidobenzoic acid and 
commercially available reagents (Figure 1). Full experimental 
details and characterisation data including high-resolution 
electrospray ionisation mass spectrometry, ultrahigh-
performance liquid chromatography (UHPLC), 1H and 13C NMR 
spectroscopy are presented in the Supporting Information. In all 
cases, semi-preparative HPLC was used to isolate the 
compounds in high purity. Compound 1 was synthesised in 37% 
yield after the N-hydroxysuccinimide activated ester (NOTA-
NHS) was reacted with a pre-synthesised[18] polyethylene glycol 
(PEG)-functionalised ArN3 reagent (N3-PEG3-NH2, Figure 2 
[green trace] and Supporting Information Figures S1 – S6). 
Compound 3 was synthesised in 89% yield via the reaction of 
DOTA-PEG4-NH2 with the activated NHS ester, 2,5-
dioxopyrrolidin-1-yl-4-azidobenzoate (2, Figures S7 – S14). 
Compound 4 was produced in 29% after direct coupling of 
DOTAGA-PEG4-NH2 with 4-azidobenzoic acid in the presence of 
HATU/DIPEA in DMF (Figures S15 – S18). Chromatographic data 
from experiments using compound 1 are presented in the main 
text. Equivalent data sets for compounds 3 and 4 are given in 
the Supporting Information. Note that the PEG linkers were 
introduced to increase the space between the chelate and the 
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photoactivatable ArN3 group. PEG groups also have the 
additional benefit of increasing water solubility which is a 
limiting factor for some chelates.[1] However, it is conceivable 
that shorter linkers or even direct coupling of ArN3 to one of the 
carboxylate arms of the chelates would also generate viable 
photoactive reagents.
Figure 1. Chemical structures of photoactivatable macrocyclic 
chelates. 
In addition to the chelates, the non-radioactive Ga 
complexes were produced and characterised by HR-ESI-MS and 
UHPLC (Figure 2, red trace, Figures S19 – S23). Radiolabelling 
experiments were monitored by radioactive instant thin layer 
chromatography (radio-iTLC) and radioactive UHPLC. 
Experiments showed that the chelates readily coordinated 
68Ga3+ ions (Figure 2, blue trace) and that the radioactive 
complexes co-eluted with the authenticated non-radioactive 
Ga-complexes as determined via comparison of the retention 
times (tR / min), and also by standard co-injection methods. For 
compound 1, formation of 68Ga-1+ was complete in <5 min. at 
room temperature. In contrast, synthesis of 68Ga-3 and 68Ga-4–, 
from the DOTA (3) and DOTAGA (4) derivatives, respectively, 
required heating to 70 oC for approximately 5 min. to affect 
complete complexation. A potentially useful feature of this set 
of chelates is that the varying number of carboxylate groups in 
compounds 1, 3 and 4, means that, under physiological 
conditions (pH7.4), the Ga3+ (and other 3+ metal ion) complexes 
will have different overall charges ranging from +1 to –1.
Following successful radiolabelling experiments on the 
chelates, the photochemical reactivity of the 68Ga-complexes 
was tested. Radiochemically pure samples of 68Ga-1+, 68Ga-3 
and 68Ga-4– were irradiated using an intense light-emitting 
diode (LED, 365 nm, 10 – 30 min., room temperature). 
Subsequent radio-iTLC and radio-UHPLC analysis confirmed that 
the radioactive complexes reacted rapidly under UV irradiation 
to give essentially a single major new radioactive species (Figure 
2, black trace). The photodegraded products each eluted with 
shorter retention times indicating that the new species are 
more hydrophilic than the parent complexes. Under the 
conditions employed, photoactivation of ArN3 produces the 
short-lived arylnitrene species in the singlet (1A2) ground 
state.[20] When the ortho-positions with respect to the N atom 
are accessible, rapid intramolecular rearrangement of the 
singlet arylnitrene occurs to give a benzazirine species that 
undergoes ring expansion to yield a ketenimine 
intermediate.[21] In the absence of more powerful nucleophiles 
(primary or secondary amines), it has been shown that the 
ketenimines intermediate reacts with water to give the more 
polar azepin-2-ol species (or equivalent tautomers[22]) as the 
major photodegradation product. Experimental data on 
photochemical reactivity of 68Ga-1+, 68Ga-3 and 68Ga-4– are 
consistent with this mechanism.
Figure 2. Normalised RP-UHPLC data showing, (green) a single 
peak for the elution of compound 1, (red) a single peak 
observed for non-radioactive complex Ga-1+, (blue) co-elution 
of 68Ga-1+ confirming the identity of the radioactive complex, 
and (black) a single peak formed after irradiation of 68Ga-1+ (365 
nm, 15 min.). Equivalent data using compounds 3 and 4 are 
presented in the supporting information.
The two-step, one-pot photoradiochemical approach for 
radiolabelling trastuzumab, and structures of the three 
products is shown in Scheme 1. Standard 68Ga3+ radiochemistry 
is not perfectly compatible with the photochemical conjugation 
step because the complexation reaction is performed under 
acidic conditions (pH~4.4, NaOAc buffer). In contrast, the 
photochemical conjugation proceeds most efficiently under 
slightly basic conditions where the nucleophilicity of the lysine 
side-chain is increased via deprotonation of the primary ε-NH2 
amine (pKa ~10.5). For this reason, the chelates were pre-
radiolabelled with [68Ga][Ga(H2O)6]3+ before adjusting the pH in 
situ to >7.5 using NaHCO3 solution. Complex formation was 
monitored by radio-iTLC and radio-size-exclusion 
chromatography (SEC) UHPLC. After complete complexation, an 
aliquot of pre-purified trastuzumab was added with an initial 
chelate-to-mAb ratio of ~10-to-1. Reaction mixtures were then 
irradiated for 15 min. at room temperature. Aliquots of the 
crude reaction mixtures were analysed by radio-iTLC, manual 
Page 2 of 5ChemComm
C
he
m
C
om
m
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bli
sh
ed
 on
 21
 D
ec
em
be
r 2
01
8. 
Do
wn
loa
de
d b
y U
niv
ers
ity
 of
 Z
uri
ch
 on
 12
/21
/20
18
 2:
07
:58
 PM
. 
View Article Online
DOI: 10.1039/C8CC09660K
Journal Name  COMMUNICATION
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 3
Please do not adjust margins
Please do not adjust margins
size-exclusion chromatography (PD-10-SEC) and radio-SEC-
UHPLC. In addition, a fraction was purified by preparative PD-10 
and spin-centrifugation methods to measure the absolute 
radiochemical yield (RCY), radiochemical purity (RCP) and molar 
activities of the purified 68Ga-radiolabelled trastuzumab (Figure 
3 and Supporting Information Figures S24 and S25). Note, all 
experiments were performed in triplicate with independent 
replicates. 
Starting from either compound 1, 3 or 4, 68Ga-radiolabelled 
trastuzumab was produced in crude radiochemical yields of 
around 16 – 18%, as measured by analytical PD-10-SEC, and 11 
– 16%, as measured by radioactive SEC-UHPLC (Figure 3). Based 
on the known initial concentrations of the reagents, the 
estimated final chelate-to-mAb ratios were in the range 1.1 to 
1.8. For the radiochemical synthesis of [68Ga]GaNOTA-azepin-
trastuzumab, the purified sample was isolated in PBS with a 
decay-corrected RCY of 10.1 ± 0.7% (n = 3), a RCP >95%, and a 
molar activity, Am of 0.46 ± 0.09 MBq nmol-1 of protein (n = 3; 
note, the protein concentration was remeasured after 
radioactive decay to obtain an accurate value). Our previous 
work found that photoradiochemical labelling does not 
compromise the biological activity (immunoreactivity) of the 
antibody.[18]
In summary, experiments showed that photoactive 
derivatives of widely used aza-macrocyclic chelates (NOTA, 
DOTA and DOTAGA) are suitable for photochemical 
radiolabelling of proteins. Introduction of these photoactive 
chelates opens the possibility of using photoradiochemical 
methods with a broad range of radionuclides taken from across 
the periodic table. Ongoing work has also found that 
photoradiochemistry is a viable tool for synthesising 
radiolabelled peptides, small-molecules and nanoparticles, and 
that entire process can be automated (data to be reported 
elsewhere).
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New photoactivatable ligands have been developed that facilitate 
one-pot photoradiochemical labelling of proteins with different 
radioactive metal ions.
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